Promotion Agreement Sample Contracts

Share Cite Term
Link

Embed (HTML)
Promotion Agreement (November 14th, 2017)

I am pleased to offer you the full-time position of President and CFO with Marrone Bio Innovations, Inc. (the "Company"), reporting to Pam Marrone, CEO. We anticipate your start date to be on August 15, 2017.

Amarin Corp – First Amendment to the Co-Promotion Agreement (August 2nd, 2017)

This First Amendment (the "Amendment") to the March 31, 2014 Co-Promotion Agreement is entered into and effective as of July 25, 2017, by and among Amarin Pharmaceuticals Ireland Limited, a company organized under the laws of Ireland (registered number 408912) with offices at 2 Pembroke House Upper Pembroke Street 28-32, Dublin 2, Ireland ("Amarin Ireland"), and Amarin Pharma, Inc., a Delaware corporation with offices at 1430 Route 206 North, Suite 101, Bedminster, NJ 07921 ("Amarin Pharma", and collectively with Amarin Ireland, "Amarin"), on the one hand, and Kowa Pharmaceuticals America, Inc., a Delaware corporation with offices at 530 Industrial Park Blvd, Montgomery, AL 36117 ("Kowa"), on the other hand (collectively, the "Parties").

Pacira Pharmaceuticals – Co-Promotion Agreement (May 4th, 2017)

This Co-Promotion Agreement (this "Agreement") is entered into this 24th day of January, 2017 (the "Effective Date"), by and between Pacira Pharmaceuticals Inc., a Delaware corporation ("Pacira"), and DePuy Synthes Sales, Inc., a Massachusetts corporation ("DePuy Synthes"). Each of Pacira and DePuy Synthes is referred to herein, individually, as a "Party" and collectively, as the "Parties."

Co-Promotion Agreement (March 14th, 2016)

This Co-Promotion Agreement (this "Agreement") is entered into as of November 4, 2015 (the "Effective Date"), by and between Eagle Pharmaceuticals, Inc., a corporation organized under the laws of Delaware with offices at 50 Tice Blvd., Suite 315, Woodcliff Lake, NJ 07677 ("Eagle") and Spectrum Pharmaceuticals, Inc., a corporation organized under the laws of Delaware with offices at 11500 South Eastern Avenue, Suite 240, Henderson, Nevada 89052 ("Spectrum"). Each of Eagle and Spectrum is sometimes referred to individually herein as a "Party" and collectively as the "Parties."

Eagle Pharmaceuticals, Inc. – Co-Promotion Agreement (February 29th, 2016)

This Co-Promotion Agreement (this "Agreement") is entered into as of November 4, 2015 (the "Effective Date"), by and between Eagle Pharmaceuticals, Inc., a corporation organized under the laws of Delaware with offices at 50 Tice Blvd., Suite 315, Woodcliff Lake, NJ 07677 ("Eagle") and Spectrum Pharmaceuticals, Inc., a corporation organized under the laws of Delaware with offices at 11500 South Eastern Avenue, Suite 240, Henderson, Nevada 89052 ("Spectrum"). Each of Eagle and Spectrum is sometimes referred to individually herein as a "Party" and collectively as the "Parties."

VNUE, Inc. – Promotion Agreement (September 14th, 2015)

This Promotion Agreement ("Agreement") is entered into effective September 10, 2015 between BookingEntertainment.com ("Promoter") of 275 Madison Avenue, 6th Floor, New York, NY 10016 and VNUE, Inc., ("VNUE"), a Nevada corporation quoted on the OTCMarkets, with offices at

Union Carbide – Second Amendment to the Second Amended and Restated Sales Promotion Agreement (October 28th, 2014)

This Second Amendment (this "Amendment") to the Second Amended and Restated Sales Promotion Agreement by and between Union Carbide Corporation ("UCC") and The Dow Chemical Company ("TDCC") dated January 1, 2004, as amended by the First Amendment dated March 22, 2013 (the "Agreement") is made effective as of July 1, 2014 (the "Effective Date").

ORASURE TECHNOLOGIES ANNOUNCES NEW CO-PROMOTION AGREEMENT FOR ORAQUICK(r) HCV RAPID ANTIBODY TEST - Investor Conference Call Scheduled Today for 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time) - (June 11th, 2014)

BETHLEHEM, Pa. - June 11, 2014 - OraSure Technologies (NASDAQ: OSUR), a market leader in point of care diagnostics, announced today that it has entered into a Master Program Services and Co-Promotion Agreement with AbbVie under which AbbVie and OraSure will co-promote the Company's OraQuick(r) HCV Rapid Test in the United States. The product will be used to test individuals at-risk for hepatitis C (HCV). OraSure will be responsible for manufacturing and selling the product directly into all markets.

Veracyte, Inc. – April 9, 2013 (September 20th, 2013)
Veracyte, Inc. – Co-Promotion Agreement (September 20th, 2013)

Genzyme Corporation, with offices located at 500 Kendall Street, Cambridge, Massachusetts 02142 (hereinafter referred to as Genzyme)

Amendment No. 1 to Co-Promotion Agreement (August 1st, 2013)

This AMENDMENT NO. 1 TO CO-PROMOTION AGREEMENT (the Amendment) is entered into on July 30, 2013 (the Amendment Effective Date), by and among Cubist Pharmaceuticals, Inc. (Cubist) and Optimer Pharmaceuticals, Inc. (Optimer). Cubist and Optimer may each be referred to herein individually as a Party and collectively as the Parties. Capitalized terms used but not defined in this Amendment have the meaning set forth in the Agreement.

Amendment No. 1 to Co-Promotion Agreement (August 1st, 2013)

This AMENDMENT NO. 1 TO CO-PROMOTION AGREEMENT (the Amendment) is entered into on July 30, 2013 (the Amendment Effective Date), by and among Cubist Pharmaceuticals, Inc. (Cubist) and Optimer Pharmaceuticals, Inc. (Optimer). Cubist and Optimer may each be referred to herein individually as a Party and collectively as the Parties. Capitalized terms used but not defined in this Amendment have the meaning set forth in the Agreement.

Inergetics Inc. – LICENSE AND PROMOTION AGREEMENT by and Between MARTHA STEWART LIVING OMNIMEDIA, INC. And Inergetics, Inc. Dated May 7, 2013 LICENSE AND PROMOTION AGREEMENT (May 15th, 2013)

THIS AGREEMENT (the "Agreement") entered into on April 10, 2013, but effective as of this 7th day of May 2013, by and between Martha Stewart Living Omnimedia, Inc. ("MSLO"), a Delaware corporation with its principal place of business at 601 West 26th Street, New York, New York 10001, and Inergetics, Inc., a Delaware corporation and Millennium Biotechnologies, Inc., a wholly-owned subsidiary of Inergetics, Inc., (Inergetics, Inc. and Millennium Biotechnologies, Inc., collectively, "Licensee"), with their principal place of business at 205 Robin Road, Suite 222 Paramus, NJ 07652 (each of MSLO and Licensee, a "Party" or "Parties").

Union Carbide – First Amendment to the Second Amended and Restated Sales Promotion Agreement (April 30th, 2013)

This First Amendment to the Second Amended and Restated Sales Promotion Agreement by and between Union Carbide Corporation ("UCC") and The Dow Chemical Company ("TDCC") dated January 1, 2004 (this "Amendment") is made effective as of March 22, 2013 (the "Effective Date").

OncBioMune Pharmaceuticals, Inc – CONFIDENTIAL BINDING TERM SHEET FOR (1) GRANISOL(r) AND AQUORAL US CO- PROMOTION AGREEMENT, (2) SALE OF EX-US RIGHTS FOR GRANISOL AND NON-BINDING TERM SHEET FOR THE ACQUISITION OF PEDIATRX INC. BY APRICUS BIOSCIENCES, INC. January 26, 2012 (January 27th, 2012)

(1) Apricus Biosciences, Inc., a Nevada corporation with its principal address at 11975 El Camino Real, Suite 300 San Diego, CA 92130 (APRICUS); and

OncBioMune Pharmaceuticals, Inc – Contract (September 14th, 2011)

***Denotes certain parts that have not been disclosed and have been filed separately with the Secretary, Securities and Exchange Commission, and is subject to a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Portlogic Systems Inc. – CLIP MOBILE - AGENT PARTNER PRODUCT DISTRIBUTION AND PROMOTION AGREEMENT Partner Term Sheet - PORTLOGIC SYSTEMS INC. Appointment of Agent (June 15th, 2011)

This Agreement is made and entered into on June 10, 2011, between Clip Mobile Inc., a Canadian Federal Corporation, located at 225-167 Church Street Toronto, ON M5B 1Y6.

KAYAK Software Corp – Confidential Treatment Amended and Restated Promotion Agreement (May 27th, 2011)

This AMENDED AND RESTATED PROMOTION AGREEMENT (this Agreement) is dated as of April 23, 2009, and effective January 1, 2009 (the Effective Date) by and between Kayak Software Corp. (Kayak), a Delaware corporation with offices at 55 North Water Street, Suite 1, Norwalk, Connecticut 06854, and Orbitz Worldwide, LLC (Orbitz), a Delaware corporation with offices at 500 West Madison Street, Suite 1000, Chicago, IL 60661.

Studio II Brands Inc – INTERNATIONAL EXCLUSIVE DISTRIBUTION AND PROMOTION AGREEMENT This Agreement, Made and Entered Into This 27 Day of June, 2009, by and Between: (May 13th, 2011)

CAFE CENTRO BRAZIL DI WURZBURGER VITTORIO & C. S.a.s. a company incorporated under the laws of Italy, with registered office in Strada privata F. Graziano n.16, 80022 Arzano (NA) Italy, hereby represented by Mr. Giovanni Wurzburger duly empowered to sign this agreement (hereinafter referred to as the "Supplier"); and

Marketing and Promotion Agreement (April 11th, 2011)

THIS AGREEMENT (this "Agreement") is made and entered into as of June 16, 2009 between Brainsway Ltd., a corporation organized under the laws of Israel having a place of business at 1st Floor, 19 Hartum Street, Har Hotzvim, Israel ("Brainsway") and ATID (Advanced Technologies Innovation Distribution SRL), an Italian corporation having a place of business at Rome Via Dora 1 ("Distributor").

Oculus Innovative Sciences – Exclusive Co-Promotion Agreement (February 18th, 2011)

This Exclusive Co-Promotion Agreement (the "Agreement"), is entered into effective as of February 14, 2011 (the "Effective Date"), by and between QUINNOVA PHARMACEUTICALS, INC., a Delaware corporation, having an address of 411 South State Street, Third Floor, Newton, Pennsylvania 18940 ("QUINNOVA"), and OCULUS INNOVATIVE SCIENCES, INC., a Delaware corporation, having an address of 1129 North McDowell Boulevard, Petaluma, California 94954 ("OCULUS").

Studio II Brands Inc – INTERNATIONAL EXCLUSIVE DISTRIBUTION AND PROMOTION AGREEMENT This Agreement, Made and Entered Into This 27 Day of June, 2009, by and Between: (February 10th, 2011)

CAFE CENTRO BRAZIL DI WURZBURGER VITTORIO & C. S.a.s. a company incorporated under the laws of Italy, with registered office in Strada privata F. Graziano n.16, 80022 Arzano (NA) Italy, hereby represented by Mr. Giovanni Wurzburger duly empowered to sign this agreement (hereinafter referred to as the "Supplier"); and

Fluidigm Corp. – FLUIDIGM CORPORATION and 454 LIFE SCIENCES, a ROCHE COMPANY CO-PROMOTION AGREEMENT (January 18th, 2011)

This Co-Promotion Agreement (the Agreement) is made this 20th day of May, 2010, by and between 454 LIFE SCIENCES CORPORATION, A ROCHE COMPANY (454 Life Sciences), a Delaware corporation , and Fluidigm Corporation (Fluidigm), both with their principal offices located at the addresses set forth above. 454 Life Sciences and Fluidigm are sometimes referred to herein collectively as the Parties and each individually as a Party.

KAYAK Software Corp – Confidential Treatment Amended and Restated Promotion Agreement (December 7th, 2010)

This AMENDED AND RESTATED PROMOTION AGREEMENT (this Agreement) is dated as of April 23, 2009, and effective January 1, 2009 (the Effective Date) by and between Kayak Software Corp. (Kayak), a Delaware corporation with offices at 55 North Water Street, Suite 1, Norwalk, Connecticut 06854, and Orbitz Worldwide, LLC (Orbitz), a Delaware corporation with offices at 500 West Madison Street, Suite 1000, Chicago, IL 60661.

Tata Communications Ltd – Tata Brand Equity & Business Promotion Agreement (September 30th, 2010)

THIS AGREEMENT is made on this 2nd day of February 2010 BETWEEN TATA SONS LIMITED, a Company incorporated under the Indian Companies Act VII of 1913 and having its registered office at Bombay House, 24, Homi Mody Street, Mumbai 400 001 (hereinafter called the Proprietor) of the First Part and :

Somaxon Pharmaceuticals – Co-Promotion Agreement (August 25th, 2010)

This PROMOTION AGREEMENT (this Agreement) is made as of August 24, 2010 (the Effective Date), by and between The Procter & Gamble Distributing Company LLC, a Delaware limited liability company (Partner), and Somaxon Pharmaceuticals, Inc., a Delaware corporation (Somaxon). Each of Somaxon and Partner is referred to herein individually as a party and collectively as the parties.

Prometheus Laboratories Inc – Distribution and Promotion Agreement (March 25th, 2010)

THIS DISTRIBUTION AND PROMOTION AGREEMENT (this Agreement) is entered into as of the 21st day of December, 2009 (the Effective Date), by and between Prometheus Laboratories Inc., a corporation organized under the laws of California, having a place of business at 9410 Carroll Park Drive, San Diego, CA 92121 (Prometheus) and Novartis Vaccines and Diagnostics, Inc., a Delaware corporation, with its principal place of business at 350 Massachusetts Avenue, Cambridge, MA 02139 (Novartis). Prometheus and Novartis are sometimes collectively referred to herein as the Parties and separately as a Party.

Middlebrook Pharmaceuticals – Promotion Agreement (March 18th, 2010)

This Promotion Agreement (Agreement) is entered into as of February 3, 2010 (Effective Date) by and between MiddleBrook Pharmaceuticals, Inc. (MBRK), a Delaware corporation with offices at 7 Village Circle, Suite 100, Westlake, TX 76262 and DoctorDirectory.com, Inc. (DD), a South Carolina Corporation, with offices at One Page Avenue, Suite 280, Asheville, NC 28801.

Asia Entertainment & Resources Ltd – Vip Junket Promotion Agreement (February 8th, 2010)

This VIP Junket Promotion Agreement ("Agreement"), dated as of January 18, 2008 is between Gillmann Investments Asia, Ltd. ("GIA"), a corporation organized and existing under the laws of South Korea, with its main office at 13F PSG Building, 563-30 Sinsa-dong, Gangnam-gu, Seoul 135-120, South Korea, and Doowell Limited ("Doowell"), a corporation organized and existing under the laws of the British Virgin Islands, with its main office at Alameda Dr, Carlos D' Assumpcao No: 181-187 Centro Comerica, Brilhantismo 12 Andar T, Macau, SAR.

Asia Entertainment & Resources Ltd – Vip Gaming Promotion Agreement (February 8th, 2010)

This VIP Gaming Promotion Agreement ("Agreement"), dated as of November 14, 2009 is made between Unicorn Incorporation. ("Unicorn"), a corporation organized and existing under the laws of the Republic of Korea ("South Korea"), with its main office at [3039-1 saekdal-dong,seigwipo-city,Jeju, South Korea, and Champion Lion Limited ("Champion"), a corporation organized and existing under the laws of the British Virgin Islands, with its main office at Alameda Dr. Carlos D' Assumpcao No: 181-187 Centro Comerica, Brilhantismo 12 Andar T, Macau, SAR.

Prometheus Laboratories Inc – Distribution and Promotion Agreement (January 26th, 2010)

THIS DISTRIBUTION AND PROMOTION AGREEMENT (this Agreement) is entered into as of the 21st day of December, 2009 (the Effective Date), by and between Prometheus Laboratories Inc., a corporation organized under the laws of California, having a place of business at 9410 Carroll Park Drive, San Diego, CA 92121 (Prometheus) and Novartis Vaccines and Diagnostics, Inc., a Delaware corporation, with its principal place of business at 350 Massachusetts Avenue, Cambridge, MA 02139 (Novartis). Prometheus and Novartis are sometimes collectively referred to herein as the Parties and separately as a Party.

Co-Promotion Agreement (January 11th, 2010)

THIS CO-PROMOTION AGREEMENT ("Agreement"), entered into as of this 7th day of January 2010, is by and between GALDERMA LABORATORIES, L.P., a Texas limited partnership, having as its principal place of business at 14501 North Freeway, Fort Worth, Texas 76177 ("PhotoMedex"), and PHOTOMEDEX, INC., a Delaware corporation, having as its principal place of business 147 Keystone Drive, Montgomeryville, PA 18936 ("PhotoMedex") (each a "party", collectively "parties").

PROMOTION AGREEMENT (The "Agreement") (December 3rd, 2009)
Service and Promotion Agreement Between Yahoo! Inc. And Intelius (October 19th, 2009)

This Service Promotion Agreement (the Agreement) is between Yahoo! Inc., a Delaware corporation with its principal place of business at 701 First Avenue, Sunnyvale, CA 94089 (Yahoo!) and Intelius, Inc., a Delaware corporation with its principal place of business at 500 108th Avenue NE, 25th Floor, Bellevue, Washington 98004 (Intelius). This Agreement is effective as of April 15, 2008 (the Effective Date). Yahoo! And Intelius collectively are referred to as the Parties and each, individually, as a Party.

Copromotion Agreement (August 5th, 2009)

This Copromotion Agreement (the Agreement) is made and entered into as of July 16, 2008 (the Effective Date), by and between Wyeth, acting through its Wyeth Pharmaceuticals Division, having a place of business at 500 Arcola Road, Collegeville, Pennsylvania 19426 (Wyeth) and Impax Laboratories, Inc., having a place of business at 30831 Huntwood Avenue, Hayward, California 94544 (Impax). Wyeth and Impax may each be referred to herein individually as a Party and collectively as the Parties.